Quan L, Uyeda A, Manabe I, Muramatsu R
J Neuroinflammation. 2025; 22(1):28.
PMID: 39891176
PMC: 11786496.
DOI: 10.1186/s12974-025-03351-4.
Syzdykbayev M, Kazymov M, Aubakirov M, Kurmangazina A, Kairkhanov E, Kazangapov R
Medicines (Basel). 2024; 11(5).
PMID: 38786549
PMC: 11123131.
DOI: 10.3390/medicines11050010.
Hu J, Zhang G, Rodemer W, Jin L, Selzer M
Front Cell Neurosci. 2024; 17:1292012.
PMID: 38179205
PMC: 10764559.
DOI: 10.3389/fncel.2023.1292012.
Denniss R, Barker L
Behav Sci (Basel). 2023; 13(5).
PMID: 37232626
PMC: 10215746.
DOI: 10.3390/bs13050388.
Zeng C, Zhang C
Front Neurosci. 2023; 17:1181816.
PMID: 37152598
PMC: 10160438.
DOI: 10.3389/fnins.2023.1181816.
Inflammation and immunomodulation in central nervous system injury - B cells as a novel therapeutic opportunity.
Maheshwari S, Dwyer L, Sirbulescu R
Neurobiol Dis. 2023; 180:106077.
PMID: 36914074
PMC: 10758988.
DOI: 10.1016/j.nbd.2023.106077.
A glial perspective on the extracellular matrix and perineuronal net remodeling in the central nervous system.
Tewari B, Chaunsali L, Prim C, Sontheimer H
Front Cell Neurosci. 2022; 16:1022754.
PMID: 36339816
PMC: 9630365.
DOI: 10.3389/fncel.2022.1022754.
Chemistry and Function of Glycosaminoglycans in the Nervous System.
Schwartz N, Domowicz M
Adv Neurobiol. 2022; 29:117-162.
PMID: 36255674
DOI: 10.1007/978-3-031-12390-0_5.
Extra Cellular Matrix Remodeling: An Adjunctive Target for Spinal Cord Injury and Intervertebral Disc Degeneration.
Kumar A, Kumar N, Pathak Z, Kumar H
Neurospine. 2022; 19(3):632-645.
PMID: 36203290
PMC: 9537846.
DOI: 10.14245/ns.2244366.183.
The Composition and Cellular Sources of CSPGs in the Glial Scar After Spinal Cord Injury in the Lamprey.
Zhang G, Jin L, Rodemer W, Hu J, Root Z, Medeiros D
Front Mol Neurosci. 2022; 15:918871.
PMID: 35832392
PMC: 9271930.
DOI: 10.3389/fnmol.2022.918871.
Pathogenesis and management of traumatic brain injury (TBI): role of neuroinflammation and anti-inflammatory drugs.
Kalra S, Malik R, Singh G, Bhatia S, Al-Harrasi A, Mohan S
Inflammopharmacology. 2022; 30(4):1153-1166.
PMID: 35802283
PMC: 9293826.
DOI: 10.1007/s10787-022-01017-8.
Retinal ganglion cell expression of cytokine enhances occupancy of NG2 cell-derived astrocytes at the nerve injury site: Implication for axon regeneration.
Ribeiro M, Ayupe A, Beckedorff F, Levay K, Rodriguez S, Tsoulfas P
Exp Neurol. 2022; 355:114147.
PMID: 35738417
PMC: 10648309.
DOI: 10.1016/j.expneurol.2022.114147.
The Role and Modulation of Spinal Perineuronal Nets in the Healthy and Injured Spinal Cord.
Sanchez-Ventura J, Lane M, Udina E
Front Cell Neurosci. 2022; 16:893857.
PMID: 35669108
PMC: 9163449.
DOI: 10.3389/fncel.2022.893857.
Saffron extract attenuates neuroinflammation in rmTBI mouse model by suppressing NLRP3 inflammasome activation via SIRT1.
Shaheen M, Bekdash A, Itani H, Borjac J
PLoS One. 2021; 16(9):e0257211.
PMID: 34506597
PMC: 8432768.
DOI: 10.1371/journal.pone.0257211.
Inhibition of Autophagy Flux Promotes Secretion of Chondroitin Sulfate Proteoglycans in Primary Rat Astrocytes.
Alizadeh J, Kochan M, Stewart V, Drewnik D, Hannila S, Ghavami S
Mol Neurobiol. 2021; 58(12):6077-6091.
PMID: 34449046
DOI: 10.1007/s12035-021-02533-4.
Substrate Specificity and Biochemical Characteristics of an Engineered Mammalian Chondroitinase ABC.
Warren P, Fawcett J, Kwok J
ACS Omega. 2021; 6(17):11223-11230.
PMID: 34056277
PMC: 8153898.
DOI: 10.1021/acsomega.0c06262.
Co-targeting myelin inhibitors and CSPGs markedly enhances regeneration of GDNF-stimulated, but not conditioning-lesioned, sensory axons into the spinal cord.
Zhai J, Kim H, Han S, Manire M, Yoo R, Pang S
Elife. 2021; 10.
PMID: 33942723
PMC: 8139830.
DOI: 10.7554/eLife.63050.
Gsx1 promotes locomotor functional recovery after spinal cord injury.
Patel M, Li Y, Anderson J, Castro-Pedrido S, Skinner R, Lei S
Mol Ther. 2021; 29(8):2469-2482.
PMID: 33895323
PMC: 8353206.
DOI: 10.1016/j.ymthe.2021.04.027.
Chondroitinase ABC Promotes Axon Regeneration and Reduces Retrograde Apoptosis Signaling in Lamprey.
Hu J, Rodemer W, Zhang G, Jin L, Li S, Selzer M
Front Cell Dev Biol. 2021; 9:653638.
PMID: 33842481
PMC: 8027354.
DOI: 10.3389/fcell.2021.653638.
Optimal Preclinical Conditions for Using Adult Human Multipotent Neural Cells in the Treatment of Spinal Cord Injury.
Won J, Yeon J, Pyeon H, Noh Y, Hwang J, Kim C
Int J Mol Sci. 2021; 22(5).
PMID: 33806636
PMC: 7961778.
DOI: 10.3390/ijms22052579.